✦ LIBER ✦

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trial

✍ Scribed by Giorgio Saracco; Elisabetta Borghesio; Pietro Mesina; Antonello Solinas; Claudia Spezia; Franco Macor; Vittorio Gallo; Livio Chiandussi; Carlo Donada; Valter Donadon; Fulvio Spirito; Alessandra Mangia; Angelo Andriulli; Giorgio Verme; Mario Rizzetto

Book ID: 118567696
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 852 KB
Volume: 27
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(97)80280-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interferon-α-2a for treatmen

Recombinant interferon-α-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study

✍ Y. Imai; S. Kawata; S. Tamura; N. Ito; K. Seki; M. Nishiuchi; Y. Shinji; K. Kiri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Comparative Effects of Different Doses o

Comparative Effects of Different Doses of Ribavirin Plus Interferon-α2b for Therapy of Chronic Hepatitis C: Results of a Controlled, Randomized Trial

✍ Herbert L. Bonkovsky; Denise Stefancyk; Kristina McNeal; Barbara F. Banner; Qin 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 103 KB

A multicenter, randomized trial of daily

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype

✍ Michael W Fried; Mitchell Shiffman; Richard K Sterling; Jeffrey Weinstein; Jeffr 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

A multicenter, randomized trial of daily

A multicenter, randomized trial of daily, high dose interferon-alpha 2b for the treatment of chronic hepatitis C: Prospective stratification by viral burden and genotype

✍ Fried, MW; Shiffman, ML; Sterling, RK; Weinstein, J; Crippin, J; Garcia, G; Wrig 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Better efficacy of a 12-month interferon

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of